DexCom
DXCM
795 hedge funds and large institutions have $29.6B invested in DexCom in 2022 Q3 according to their latest regulatory filings, with 79 funds opening new positions, 289 increasing their positions, 311 reducing their positions, and 72 closing their positions.
22% more funds holding in top 10
Funds holding in top 10: 9 → 11 (+2)
7% more capital invested
Capital invested by funds: $27.6B → $29.6B (+$1.97B)
10% more first-time investments, than exits
New positions opened: 79 | Existing positions closed: 72
0% less funds holding
Funds holding: 798 → 795 (-3)
0.84% less ownership
Funds ownership: 94.36% → 93.52% (-0.84%)
7% less repeat investments, than reductions
Existing positions increased: 289 | Existing positions reduced: 311
18% less call options, than puts
Call options by funds: $324M | Put options by funds: $398M
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Wellington Management Group
Boston,
Massachusetts
|
+$279M |
| 2 |
Capital Research Global Investors
Los Angeles,
California
|
+$241M |
| 3 |
VOYA Investment Management
Atlanta,
Georgia
|
+$128M |
| 4 |
Fisher Asset Management
Camas,
Washington
|
+$91M |
| 5 |
PCH
Polar Capital Holdings
London,
United Kingdom
|
+$70.7M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Citadel Advisors
Miami,
Florida
|
-$205M |
| 2 |
AI
Alphabet Inc
Mountain View,
California
|
-$185M |
| 3 |
Allianz Asset Management
Munich,
Germany
|
-$161M |
| 4 |
Jennison Associates
New York
|
-$137M |
| 5 |
Janus Henderson Group
London,
|
-$102M |
DXCM Hedge Fund Activity: Q3 2022 in Review
795 of the 5,828 institutional investors tracked by Wall St. Rank reported a position in DexCom (DXCM) for Q3 2022, worth a combined $29.6B — up 7.1% from $27.6B a quarter earlier.
Buyers outnumbered sellers: 79 funds opened new DXCM positions and 72 closed out — a net gain of 7 holders — while 289 added to existing stakes and 311 trimmed.
The largest buyer was Wellington Management Group, adding an estimated $279M. The largest seller was Citadel Advisors, cutting an estimated $205M.
- 795 institutional investors held DexCom (DXCM) as of Q3 2022, down from 798 in Q2 2022.
- Funds reported $29.6B of DexCom stock for Q3 2022, up 7.1% quarter-over-quarter.
- 79 funds opened new DexCom positions in Q3 2022 and 72 closed out, a net change of +7 holders.
- The largest DexCom buyer in Q3 2022 was Wellington Management Group, an estimated $279M added.
- The largest DexCom seller in Q3 2022 was Citadel Advisors, an estimated $205M sold.
Based on aggregated 13F filings for Q3 2022.